Early prediction of the differentiation potential during the formation of human iPSC-derived embryoid bodies.


Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
27 08 2019
Historique:
received: 25 05 2019
accepted: 16 06 2019
pubmed: 30 6 2019
medline: 7 7 2020
entrez: 29 6 2019
Statut: ppublish

Résumé

Induced pluripotent stem cells (iPSCs) show huge variations in their differentiation potential, even in the same condition. However, methods for predicting these differentiation tendencies, especially in the early stage of differentiation, are still scarce. This study aimed to establish a simple and practical system to predict the differentiation tendency of iPSC lines using embryoid bodies (EBs) with identified parameters in the early stage. We compared four human iPSC lines in terms of the morphology and maintenance of EBs and their gene expression levels of specific markers for three germ-layers. Furthermore, the differentiation potentials of these iPSC lines into melanocytes, which are ectoderm-derived cells, were also compared and correlated with the above parameters. The results showed that iPSC lines forming regular, smooth, and not cystic EBs, which could be maintained in culture for a relatively longer time, also expressed higher levels of ectoderm-specific markers and lower levels of mesoderm/endoderm markers. Additionally, these iPSC lines showed greater potential in melanocyte differentiation using EB-based protocol, and the induced melanocytes expressed melanocytic markers and presented characteristics that were similar to those of normal human melanocytes. By contrast, iPSC lines that formed cystic EBs with bright or dark cavities and expressed relatively lower levels of ectoderm-specific markers failed in the melanocyte differentiation. Collectively, the differentiation tendency of human iPSC lines may be predicted by specific parameters in the EB stage. The formation and maintenance of optimal EBs and the expression of germ layer-specific markers are particularly important and practical for the prediction assay in the early stage.

Identifiants

pubmed: 31248595
pii: S0006-291X(19)31221-5
doi: 10.1016/j.bbrc.2019.06.081
pii:
doi:

Substances chimiques

Nanog Homeobox Protein 0
Octamer Transcription Factor-3 0
POU5F1 protein, human 0
SOX2 protein, human 0
SOXB1 Transcription Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

673-679

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Ning-Ning Guo (NN)

Jiangsu University Institute of Regenerative Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212001, China.

Li-Ping Liu (LP)

Jiangsu University Institute of Regenerative Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212001, China.

Yi-Xuan Zhang (YX)

Jiangsu University Institute of Regenerative Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212001, China.

Yu-Tian Cai (YT)

Jiangsu University Institute of Regenerative Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212001, China.

Yuan Guo (Y)

Jiangsu University Institute of Regenerative Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212001, China.

Yun-Wen Zheng (YW)

Jiangsu University Institute of Regenerative Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212001, China; University of Tsukuba Faculty of Medicine, Tsukuba, Ibaraki, 305-8575, Japan; Yokohama City University School of Medicine, Yokohama, Kanagawa, 236-0004, Japan. Electronic address: ywzheng@md.tsukuba.ac.jp.

Yu-Mei Li (YM)

Jiangsu University Institute of Regenerative Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212001, China. Electronic address: yumeili@ujs.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH